Skip to main content
. 2021 Feb 9;13(4):704. doi: 10.3390/cancers13040704

Figure 1.

Figure 1

Overview of the study cohort. Of 336 patients with extrauterine carcinoma, 91 patients were excluded because patients did not receive neoadjuvant chemotherapy (NACT) (N = 79), tumor histology was not high-grade serous carcinoma (HGSC) (N = 8), staging information was not available (N = 3), or the date of initial NACT was unknown (N = 1). We included the remaining 245 patients in our analysis. Chemotherapy response score, CRS.